上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
Garsorasib
Garsorasib 是一种有效的 KRAS G12C 抑制剂，其 IC50 值为10 nM。Garsorasib 具有研究胰腺癌、子宫内膜癌、结直肠癌或肺癌 (非小细胞肺癌) 等多种癌症的潜力 (信息摘自专利 WO2020233592A1，化合物 2)。
Garsorasib Chemical Structure
CAS No. : 2559761-14-5
| 规格 | 是否有货 | ||
|---|---|---|---|
| 100 mg | 询价 | ||
| 250 mg | 询价 | ||
| 500 mg | 询价 |
* Please select Quantity before adding items.
| 生物活性 |
Garsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1]. |
|
|---|---|---|
| IC50 & Target |
|
|
| 分子量 |
598.65 |
|
| Formula |
C32H32F2N8O2 |
|
| CAS 号 |
2559761-14-5 |
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
|
| 参考文献 |
|
所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务